Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,344 | 161,657 | 124,220 | 153,088 | 186,567 |
| Receivables | 132 | 186 | 177 | 837 | 967 |
| TOTAL | $142,212 | $171,341 | $132,832 | $161,423 | $193,964 |
| Non-Current Assets | |||||
| PPE Net | 2,686 | 3,196 | 3,733 | 4,306 | 4,885 |
| Other Non-Current Assets | 9,324 | 9,430 | 9,913 | 11,742 | 13,269 |
| TOTAL | $12,010 | $12,626 | $13,646 | $16,048 | $18,154 |
| Total Assets | $154,222 | $183,967 | $146,478 | $177,471 | $212,118 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,800 | 8,762 | 5,944 | 6,773 | 8,292 |
| Accrued Expenses | 15,773 | 15,342 | 25,529 | 26,963 | 28,478 |
| TOTAL | $28,064 | $26,512 | $33,799 | $35,983 | $38,939 |
| Non-Current Liabilities | |||||
| Long Term Debt | 176,285 | 174,994 | 100,559 | 99,917 | 99,279 |
| Other Non-Current Liabilities | 2,850 | 3,496 | 4,127 | 4,741 | 5,341 |
| TOTAL | $179,135 | $178,490 | $104,686 | $104,658 | $104,620 |
| Total Liabilities | $207,199 | $205,002 | $138,485 | $140,641 | $143,559 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,718 | 14,671 | 14,607 | 14,544 | 14,485 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -316,278 | -279,628 | -246,187 | -213,353 | -178,097 |
| TOTAL | $-52,977 | $-21,035 | $7,993 | $36,830 | $68,559 |
| Total Liabilities And Equity | $154,222 | $183,967 | $146,478 | $177,471 | $212,118 |